ETON · Eton Pharmaceuticals Inc
AI read · Good for ETON
The AI's read
Eton popped after a clear Q2 beat and FY26 revenue guidance above estimates. The print showed 43c EPS vs 10c consensus and $37.568M sales vs $27.119M consensus, sparking a ~22% premarket jump. The market has already moved hard. RSI 76 and a roughly +20% move compress near-term upside and raise short-term pullback risk. We lean bullish because beats plus raised guidance matter for a niche pharma with distribution momentum. Conviction is tempered by the big pre-market run and overbought technicals, so size and timing matter.